Benzinga - Thu, 15 Apr 2021 05:58:20 -0400
Benzinga - Wed, 14 Apr 2021 12:09:23 -0400
Benzinga - Wed, 14 Apr 2021 04:58:58 -0400
Benzinga - Mon, 22 Feb 2021 05:59:48 -0400
Benzinga - Fri, 19 Feb 2021 13:47:30 -0400
Benzinga - Fri, 19 Feb 2021 09:08:18 -0400
Benzinga - Fri, 19 Feb 2021 08:02:08 -0400
Benzinga - Thu, 18 Feb 2021 17:54:11 -0400
Benzinga - Thu, 18 Feb 2021 11:18:02 -0400
Benzinga - Thu, 18 Feb 2021 09:13:43 -0400
load more
Sector: Health Care.Industry: Biotechnology
Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for the prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-21
REV
Q4 2020Est.ActualSurprise
EPS-0.050
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CBLICleveland BioLabs3.98%84.9M

Cleveland BioLabs Company Questions & Answers

Q

How do I buy Cleveland BioLabs (CBLI) stock?

A

You can purchase shares of Cleveland BioLabs (NASDAQ: CBLI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cleveland BioLabs's (CBLI) main competitors?

A

Other companies in Cleveland BioLabs’s space includes: Celyad Oncology (NASDAQ:CYAD), Cellectar Biosciences (NASDAQ:CLRB) and Addex Therapeutics (NASDAQ:ADXN).

Q

What is the target price for Cleveland BioLabs?

A

The latest price target for Cleveland BioLabs (NASDAQ: CBLI) was reported by Cantor Fitzgerald on 2014-01-24. The analyst firm set a price target for 0.00 expecting CBLI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is Cleveland BioLabs (CBLI) stock ?

A

The stock price for Cleveland BioLabs (NASDAQ: CBLI) is $5.49 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Cleveland BioLabs (CBLI) dividend?

A

There are no upcoming dividends for Cleveland BioLabs.

Q

When is Cleveland BioLabs (NASDAQ:CBLI) reporting earnings?

A
Cleveland BioLabs’s Q1 earnings are confirmed after-market from now on May 21, 2021.
Q

When is the upcoming split for CBLI?

A

There is no upcoming split for Cleveland BioLabs.